| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/13/2004 | CN1537111A Urea substituted imidazoquinolines |
| 10/13/2004 | CN1537105A Quinazolines as MMP-13 inhibitors |
| 10/13/2004 | CN1537101A Pyridine matrix metalloproteinase inhibitors |
| 10/13/2004 | CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 10/13/2004 | CN1537025A 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide |
| 10/13/2004 | CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor |
| 10/13/2004 | CN1537012A Use of long pentraxin PTX3 for treatment of FGF-3 mediated tumour diseases |
| 10/13/2004 | CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method |
| 10/13/2004 | CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases |
| 10/13/2004 | CN1537002A Novel theterocyclic analogs of diphenylethylene compounds |
| 10/13/2004 | CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 10/13/2004 | CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
| 10/13/2004 | CN1536996A (-)-olivil as antioxidant |
| 10/13/2004 | CN1536995A Antitumor compositions containing taxane derivatives |
| 10/13/2004 | CN1536993A Solid pharmaceutical composition comprising 4-cyano-trifluoro-N-[3-(40fluorophenylsulphonyl)2-hydroxy-2-methylpropiono]-m-toluidide and PVP |
| 10/13/2004 | CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 10/13/2004 | CN1536990A Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 10/13/2004 | CN1536988A Sustained-release delivery system |
| 10/13/2004 | CN1536083A Low virulent vero strain |
| 10/13/2004 | CN1536079A 修饰的精氨酸脱亚氨酶 Modified arginine deiminase |
| 10/13/2004 | CN1535985A Genetically-engineered single chain antibody scFv 25 for resisting liver cancen |
| 10/13/2004 | CN1535983A Blood vessel generating inhibitor |
| 10/13/2004 | CN1535971A Fermentation preparation method of cell inhibitor and its crystal form |
| 10/13/2004 | CN1535957A New isoquinoline compounds, their preparation method and medicine composition contaning them |
| 10/13/2004 | CN1535729A Tumor gene vaccine based on ectopic chorionic gonadotropin beta and its preparation method |
| 10/13/2004 | CN1535728A Drug composition for curing disease produced from IL-6 |
| 10/13/2004 | CN1535712A New anticancer medicine |
| 10/13/2004 | CN1535699A Medicine for curing malignant tumors of carcinoma of prostate, liver cancer and sarcoma |
| 10/13/2004 | CN1535694A Chinese medicine for curing tumor and its production method |
| 10/13/2004 | CN1535689A Medicine composition for curing tumor |
| 10/13/2004 | CN1535688A Combined preparation containing morpholine anthracene nucleus compound and autcancer preparation |
| 10/13/2004 | CN1535679A Medicine composition containing taxol substance and its preparation method |
| 10/13/2004 | CN1170931C Vasculogenesis correlation molecule |
| 10/13/2004 | CN1170930C Antisense oligonuleotide structure and use using fade-inhibition factor API4 as target |
| 10/13/2004 | CN1170929C Human protein able to suppress growth of cancer cells and its coding sequence |
| 10/13/2004 | CN1170928C Liver cancer related gene and its application |
| 10/13/2004 | CN1170850C Human angiogenin-like protein and coding sequence and application thereof |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170848C Novel human hepatoma associated protein and coding sequence thereof |
| 10/13/2004 | CN1170845C Giant-web bombinator antineoplastic protein and its prepn and gene |
| 10/13/2004 | CN1170593C Immunogenic compsns to CK-b/gastrin-receptor and methods for treatment of tumors |
| 10/13/2004 | CN1170588C Orally applied medicine containing Nostoc which expressing human tumor necrosin factor alpha |
| 10/13/2004 | CN1170587C I (Robinia Pseudoacacia) lectin and its uses |
| 10/13/2004 | CN1170586C Pharmaceutical formulation of Didemnin compound |
| 10/13/2004 | CN1170565C Cancer treating astringent medicine decoction |
| 10/13/2004 | CN1170556C Chinese medicine for treating neoplasm |
| 10/13/2004 | CN1170533C Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 10/12/2004 | US6803373 Synergistic mixtures; enhanced absorption |
| 10/12/2004 | US6803371 For treating cellular proliferative and neurodegenerative diseases |
| 10/12/2004 | US6803359 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/12/2004 | US6803199 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 10/12/2004 | US6803189 Methods for the detection of cervical cancer |
| 10/12/2004 | US6803052 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma |
| 10/12/2004 | CA2387401C Compositions, methods and systems for the production of enediynes |
| 10/11/2004 | CA2423897A1 Methods for treating lung infections and lung tumors and for treating and preventing lung metastases |
| 10/07/2004 | WO2004085654A2 Modulation of cell phenotype by inhibitory rna |
| 10/07/2004 | WO2004085653A1 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
| 10/07/2004 | WO2004085452A1 Compound having affinity with calcified tissue |
| 10/07/2004 | WO2004085442A2 New calix arene compounds, their process of preparation and their use, particularly as enzymatic mimes |
| 10/07/2004 | WO2004085441A1 New calix arene compounds, their process of preparation and their use, particularly as enzymatic mimes |
| 10/07/2004 | WO2004085436A2 Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 10/07/2004 | WO2004085434A1 Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
| 10/07/2004 | WO2004085425A1 Fused azoles such as 2,5-disubstituted benzimidazoles, benzoxazoles and benzothiazoles as kinase inhibitors |
| 10/07/2004 | WO2004085418A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 10/07/2004 | WO2004085409A2 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof |
| 10/07/2004 | WO2004085388A2 Cyclic protein tyrosine kinase inhibitors |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084928A1 S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment |
| 10/07/2004 | WO2004084926A1 Cell- and gland-restorative and/or anti-carcinogenic liquid agave extract and method of obtaining same |
| 10/07/2004 | WO2004084917A1 Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs |
| 10/07/2004 | WO2004084893A1 Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive wt p53 |
| 10/07/2004 | WO2004073728A3 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 10/07/2004 | WO2004069999A3 Screening method |
| 10/07/2004 | WO2004064855A8 Medicament and use thereof for tumor therapy |
| 10/07/2004 | WO2004052282A3 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents |
| 10/07/2004 | WO2004048386A3 THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AND THIENO[2,3-b]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS |
| 10/07/2004 | WO2004024880A3 AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 10/07/2004 | WO2004012659A3 Nitrosated proton pump inhibitors, compositions and methods of use |
| 10/07/2004 | WO2004007709A3 Production of polyketides |
| 10/07/2004 | WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists |
| 10/07/2004 | WO2003101386A3 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 10/07/2004 | WO2003074027A8 Self emulsifying drug delivery systems for poorly soluble drugs |
| 10/07/2004 | WO2003072603A9 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 10/07/2004 | WO2003059942A3 Peptides and peptidomimetics having anti-proliferative activity and their use |
| 10/07/2004 | WO2003049679A3 Mitotic kinesin inhibitors |
| 10/07/2004 | WO2002078636A3 Detection and treatment of colorectal cancer |
| 10/07/2004 | US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis |
| 10/07/2004 | US20040198981 Tricyclic dihydroquinoline derivatives,method for preparing same and pharmaceutical compositions containing same |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198976 Method for synthesizing pyrazolobenzodiazepines |
| 10/07/2004 | US20040198832 Compositions and methods for treating amyloidosis |
| 10/07/2004 | US20040198830 Carbamic acid compounds comprising an ether linkage as hdac inhibitors |
| 10/07/2004 | US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects |
| 10/07/2004 | US20040198804 i.e., 3-[3,5-dimethyl-4-[3-oxo-3-(piperazin-1-ylpropyl]-1H-pyrrol-2-ylmethylene]-1,3-dihydroindol-2-one, in which the piperazine may be 4-substituted with methyl or ethyl and salts are tyrosine kinase inhibitors used to treat various kinds of cancer |
| 10/07/2004 | US20040198794 Ondansetron forms and processes of making the same |
| 10/07/2004 | US20040198784 Antitumor agents for treating a tumor of the colon or rectum in a mammal; N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt |
| 10/07/2004 | US20040198783 Targeted bone marrow protection agents |
| 10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |